comparemela.com

Page 15 - Dr Reddy Laboratories Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Antacids Markets Report 2022-2023 & 2023-2027: Poor Lifestyle Adoptions and Irregular Dietary Habits to Drive Demand

India s Zydus Lifesciences beats Q3 profit view on strong India, U S sales

BENGALURU (Reuters) - Indian generic drugmaker Zydus Lifesciences Ltd reported a bigger-than-expected 24.5% rise in third-quarter profit on Friday, he.

Focus On Budget Boost After $68 Billion Rout In Adani Group Shares

Prime Minister Narendra Modi's government will present its annual budget to the parliament on Wednesday. The plan is expected to boost funds for infrastructure, defense and logistics, providing windfalls for related companies.

US antitrust lawsuit against Dr Reddy s voluntarily dismissed

Claims against Dr Reddy s over Revlimid in US dismissed - Jammu Kashmir Latest News | Tourism

NEW DELHI, Dec 29: Dr Reddy’s Laboratories on Thursday said all claims against it in the antitrust litigation filed in the US, related to a prescription medicine Revlimid, used in treatment of multiple myeloma have been dismissed. In a regulatory filing, the company said on December 22, 2022 and December 27, 2022, the plaintiffs voluntarily dismissed Dr Reddy’s Laboratories Ltd and Dr Reddy’s Laboratories, Inc. Respectively, from the case. “All claims against the company in the litigation have now been […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.